Morgan Stanley Vitality Portfolio C (MSVMX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

6.36

0.00 (0.00%)

Jul 2, 2026, 4:00 PM EST

21.37% (1Y)

Fund Assets	2.29M
Expense Ratio	2.05%
Min. Investment	$1,000
Turnover	n/a
Dividend (ttm)	0.10
Dividend Yield	1.50%
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jun 9, 2026

Previous Close	6.36
YTD Return	-0.34%
1-Year Return	23.18%
5-Year Return	n/a
52-Week Low	5.05
52-Week High	6.72
Beta (5Y)	n/a
Holdings	33
Inception Date	Dec 31, 2021

About MSVMX

Morgan Stanley Institutional Fund, Inc. Vitality Portfolio Class C is a mutual fund focused on long-term capital appreciation through investment in the U.S. healthcare sector. The fund primarily targets companies engaged in the discovery, development, production, or distribution of products and services driven by advances in healthcare. Its portfolio is actively managed, with an emphasis on firms that demonstrate sustainable competitive advantages, robust research and development pipelines, financial strength, and favorable risk/reward profiles. The fund includes holdings in leading industry players such as pharmaceuticals, biotechnology, medical devices, and healthcare services. This approach offers exposure to one of the most dynamic and innovative segments of the U.S. equity market. The fund’s investment philosophy seeks to capitalize on growth trends within healthcare, supporting its role as a specialized option for investors aiming to participate in the ongoing evolution of medical technologies and services.

Category Health

Performance Rating Below Average

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol MSVMX

Share Class Class C

Index Russell 3000 TR

Performance

MSVMX had a total return of 23.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.67%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MSVOX	Class R6	0.90%
MSVDX	Class I	0.95%
MSVEX	Class A	1.30%

Top 10 Holdings

49.09% of assets

Name	Symbol	Weight
argenx SE	ARGX	8.03%
Eli Lilly and Company	LLY	7.79%
Ascendis Pharma A/S	ASND	5.48%
Nektar Therapeutics	NKTR	4.75%
Thermo Fisher Scientific Inc.	TMO	4.28%
Align Technology, Inc.	ALGN	4.18%
Enliven Therapeutics, Inc.	ELVN	3.90%
10x Genomics, Inc.	TXG	3.77%
NewAmsterdam Pharma Company N.V.	NAMS	3.57%
Structure Therapeutics Inc.	GPCR	3.36%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 9, 2026	$0.05761	Jun 9, 2026
Dec 11, 2025	$0.0379	Dec 11, 2025

Full Dividend History